The umpire strikes back
This article was originally published in SRA
Executive Summary
Countries around the world are joining forces to tackle some of the strategies used by multinational pharmaceutical companies to secure their market share, keep up drug prices and maximize their revenues. At least that's the way it seems, as the supposed arbiters of fair play come down hard on suspected antitrust behavior and drug price inflation.